David Walcott: Blood Supply as Essential Healthcare Infrastructure
David Walcott, Co-Managing Partner at Novamed Ventures, shared World Health Organization‘s post on LinkedIn:
“Blood systems are increasingly being understood not just as a hospital resource, but as critical national infrastructure that underpins modern healthcare.
Awareness efforts from the World Health Organization highlight the essential role that blood and plasma donations play across a wide range of medical conditions – from childbirth complications and trauma to cancer treatment, bleeding disorders, immune deficiencies, and chronic diseases.
What’s striking is how many aspects of healthcare depend on a reliable blood supply.
Unlike many medical products, blood cannot be manufactured at scale, making voluntary donation one of the few healthcare resources that depends directly on community participation.
That’s why health systems increasingly focus on strengthening blood collection, testing, storage, and distribution networks.
Safe and timely access to blood products is a prerequisite for effective emergency care, surgery, maternal health services, oncology treatment, and many other essential health interventions.
The implication is that resilient healthcare systems require more than hospitals, medicines, and healthcare workers – they also require sustainable donation ecosystems capable of meeting ongoing demand.
If blood donation rates remain strong and blood services continue to improve, millions of patients worldwide will have access to life-saving treatments that would otherwise be unavailable, demonstrating how individual acts of contribution can create profound public health impact.”
World Health Organization shared a post on LinkedIn:
“Chronic blood conditions.
Childbirth complications.
Cancer treatment.
Bleeding disorders.
Immune deficiencies.
Safe blood and plasma donations provide a critical lifeline for patients facing these and many other life-threatening conditions.
Everyone everywhere should have timely access to safe blood and blood products.”
Stay updated with Hemostasis Today.
-
Sep 22, 2026, 16:45Claudiu Stoicescu: Are We Starting Cardiovascular Risk Assessment Too Late?
-
Sep 22, 2026, 16:20Ila Bappa Ibrahim: Bringing Sickle Cell Innovation Closer to Communities
-
Sep 22, 2026, 16:02Ana Pedrero Gil: Peri-operative Management of Patients Undergoing Day Surgery
-
Sep 22, 2026, 15:27Zia Ullah: RBC-Derived Extracellular Vesicles as Potential Biomarkers of Thrombotic Risk in Dengue
-
Sep 22, 2026, 15:01Lesley Van Wyk: What Each Iron Markers Actually Mean
-
Sep 22, 2026, 14:37Chokri Ben Lamine։ Saudi Arabia Leads A New Milestone In Hemophilia A Care
-
Sep 22, 2026, 13:58Giulia Passaniti: Dual Inferior Vena Cava Anatomy in Tetralogy of Fallot
-
Sep 22, 2026, 13:35Michael Miyamoto: Scaling Guideline Based Lipid Management in Community Practice
-
Sep 22, 2026, 13:15Suvro Sankha Datta: Developing Blood Group Genotyping Platform Using a Gold-Oligo